Selectis Health, Inc.
GBCS · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.04 | -0.05 | 1.63 | 0.02 |
| FCF Yield | -54.82% | 3.86% | -3.69% | -4.08% |
| EV / EBITDA | 29.29 | -6.70 | 33.71 | 53.72 |
| Quality | ||||
| ROIC | -10.18% | -25.90% | -0.74% | -1.75% |
| Gross Margin | 23.13% | 14.70% | 26.45% | 26.68% |
| Cash Conversion Ratio | 0.75 | -0.14 | 0.13 | 0.12 |
| Growth | ||||
| Revenue 3-Year CAGR | -0.92% | 7.89% | 24.72% | 61.68% |
| Free Cash Flow Growth | -467.06% | 196.09% | 33.27% | -145.21% |
| Safety | ||||
| Net Debt / EBITDA | 26.45 | -4.90 | 24.21 | 34.42 |
| Interest Coverage | -1.33 | -4.12 | -0.13 | -0.29 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -54.85 | -49.57 | -18.43 | -30.84 |